US equities
|
MU
$928.76
▲+0.00%
SNDK
$1,304.84
▲+0.00%
SKHY
$145.36
▲+0.00%
TSLA
$407.46
▲+0.00%
NVDA
$217.94
▲+0.00%
INTC
$93.74
▲+0.00%
GOOGL
$320.58
▲+0.00%
STX
$667.85
▲+0.00%
MU
$928.76
▲+0.00%
SNDK
$1,304.84
▲+0.00%
SKHY
$145.36
▲+0.00%
TSLA
$407.46
▲+0.00%
NVDA
$217.94
▲+0.00%
INTC
$93.74
▲+0.00%
GOOGL
$320.58
▲+0.00%
STX
$667.85
▲+0.00%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Latest News about Phase 3 Clinical Trial
Recent news which mentions Phase 3 Clinical Trial
UK Supports Psychedelic Research With Phase 3 Trial In Federal Health Sites
December 13, 2022
Tickers
AWKNF
Tags
Psychedelics
Penny Stocks
UK National Health Service
From
Benzinga
MAPS Completes Second Phase 3 Trial Of MDMA-Assisted Therapy For PTSD, Topline Data & New Drug Application Next
November 17, 2022
Tags
FDA
News
MDMA/assisted therapy
From
Benzinga
Compass Pathways Will Lead Two Concurrent Phase 3 Trials On Psilocybin-Assisted Therapy For Depression
October 12, 2022
Tickers
CMPS
Tags
CMPS
Small Cap
Psychedelics
From
Benzinga